Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-24-267204
Filing Date
2024-11-27
Accepted
2024-11-27 16:30:58
Documents
4

Document Format Files

Seq Description Document Type Size
1 POS AM d810850dposam.htm POS AM 425523
2 EX-23.1 d810850dex231.htm EX-23.1 1721
3 EX-23.2 d810850dex232.htm EX-23.2 1926
4 GRAPHIC g810850g87y32.jpg GRAPHIC 33507
  Complete submission text file 0001193125-24-267204.txt   476654
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: POS AM | Act: 33 | File No.: 333-276774 | Film No.: 241511684
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)